Breaking News Instant updates and real-time market news.

CSCO

Cisco

$56.20

-0.41 (-0.72%)

, ACIA

Acacia Communications

$48.13

0.05 (0.10%)

08:01
07/09/19
07/09
08:01
07/09/19
08:01

Cisco to acquire Acacia Communications for $70.00 per share in cash, or $2.6B

CSCO

Cisco

$56.20

-0.41 (-0.72%)

ACIA

Acacia Communications

$48.13

0.05 (0.10%)

  • 16

    Jul

  • 14

    Aug

CSCO Cisco
$56.20

-0.41 (-0.72%)

06/12/19
06/12/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Cisco (CSCO) downgraded to Market Perform from Outperform at William Blair with analyst Jason Ader saying he sees "signs of tightening demand" across IT infrastructure, which he believes could pressure growth in Cisco's fiscal 2020, "especially when compared against unusually strong demand in fiscal 2019." 2. Manpower (MAN) downgraded to Neutral from Outperform at Credit Suisse. 3. Dave & Buster's (PLAY) downgraded to Hold from Buy at Gordon Haskett and SunTrust, as well as to Market Perform from Outperform at Wells Fargo. 4. Amcor (AMCR) reinstated with a Sell from Neutral at Goldman Sachs with analyst Brian Maguire saying Bemis's earnings growth "has not proven to be as resilient in recent years." 5. Beyond Meat (BYND) downgraded to Market Perform from Outperform at Bernstein with analyst Alexia Howard saying "valuation considerations as the stock has traded in a highly volatile manner since its IPO likely due to its limited public float." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/25/19
COWN
06/25/19
NO CHANGE
COWN
Outperform
Cisco remains our "Best idea", says Cowen
Cowen analyst Paul Silverstein said Cisco remains his "Best idea" for 2019. He cited confidence in its earnings power from an improving comps position, ongoing shift to recurring software revenue, and increasing strategic significance of the network. Silverstein reiterated his Outperform rating and $65 price target on Cisco shares.
07/03/19
RILY
07/03/19
NO CHANGE
Target $5
RILY
Buy
Finjan kept 'all-important' system claims in patent ruling, says B. Riley FBR
The U.S. Court of Appeals for the Federal Circuit yesterday affirmed prior U.S. Patent Trial and Appeal Board inter partes review rulings that affirm the patentability of claims of one of Finjan Holdings' (FNJN) workhorse patents against Palo Alto Networks, B. Riley FBR analyst Mike Crawford tells investors in a research note. While Finjan didn't regain prior stricken method claims, it did retain its "all-import" system claims in the patent, says the analyst. Further, he believes the CAFC cleared up an unintentional delay on delayed priority claim issue that quashes any inequitable conduct arguments not only in the Palo Alto case but also in others such as Juniper Networks (JNPR) and Cisco Systems (CSCO) where Finjan also is asserting this patent. Crawford now expects Finjan to ask the judge to lift the stay, "setting the wheels in motion to grind toward a potential jury trial." He keeps a Buy rating on the shares with a $5 price target.
07/08/19
SBSH
07/08/19
DOWNGRADE
Target $24
SBSH
Sell
Juniper downgraded to Sell from Neutral at Citi
Citi analyst Jim Suva downgraded Juniper Networks (JNPR) to Sell from Neutral and cut his price target for the shares to $24 from $28. The analyst has picked up recent competitive share gains by Arista Networks (ANET) and Cisco Systems (CSCO). This sets up for more share loss to Juniper and "too lofty" expectations in the second half of 2019, Suva tells investors in a research note.
ACIA Acacia Communications
$48.13

0.05 (0.10%)

05/06/19
05/06/19
UPGRADE
Target $64

Neutral
Acacia Communications upgraded to Neutral at BofA/Merrill
As previously reported, BofA/Merrill upgraded Acacia Communications to Neutral from Underperform and raised its price target to $64 from $40. Analyst Tal Liani believes Acacia is well positioned to benefit from China's 5G build-out and new Data Center products, but notes customer concentration is a key risk given Chinese vendor inventory build-out.
07/01/19
NEED
07/01/19
UPGRADE
NEED
Buy
Acacia Communications upgraded to Buy from Hold at Needham
07/01/19
NEED
07/01/19
UPGRADE
Target $59
NEED
Buy
Acacia Communications upgraded to Buy from Hold at Needham
Needham analyst Alex Henderson upgraded Acacia Communications (ACIA) to Buy from Hold with a $59 price target following a round of industry checks and visits. In a research note to investors, Henderson says he believes the landscape is improving for Acacia, as well as for Ciena (CIEN) and Infinera (INFN). By driving more rapid new DSP introductions, the analyst says Acacia has pressured its competitors to keep pace, which he says they are not. He thinks Acacia will gain share, lock in customers, and enhance their advantage on the next chip development cycle.
07/02/19
PIPR
07/02/19
NO CHANGE
PIPR
Piper sees 'interesting opportunities' in Optical Networking space
The trade war concerns have created some "interesting opportunities" within the Optical Networking space as underlying demand trends remain solid, Piper Jaffray analyst Troy Jensen tells investors in a research note. The analyst believes investors should revisit some select names and he highlights Acacia Communications (ACIA), Fabrinet (FN) and Lumentum (LITE). He continues to view Acacia as one of the best optical stocks to own and would be buyers at current levels.

TODAY'S FREE FLY STORIES

AKG

Asanko Gold

$0.83

0.0341 (4.29%)

, GFI

Gold Fields

$5.51

-0.16 (-2.82%)

07:28
07/23/19
07/23
07:28
07/23/19
07:28
Hot Stocks
Asanko Gold outlines 2H19 exploration program »

Asanko Gold (AKG)…

AKG

Asanko Gold

$0.83

0.0341 (4.29%)

GFI

Gold Fields

$5.51

-0.16 (-2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADPT

Adaptive Biotechnologies

$39.16

0.61 (1.58%)

, MSFT

Microsoft

$138.41

1.79 (1.31%)

07:27
07/23/19
07/23
07:27
07/23/19
07:27
Initiation
Adaptive Biotechnologies, Microsoft, Roche initiated  »

Adaptive Biotechnologies…

ADPT

Adaptive Biotechnologies

$39.16

0.61 (1.58%)

MSFT

Microsoft

$138.41

1.79 (1.31%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 02

    Sep

  • 09

    Sep

  • 04

    Nov

NDAQ

Nasdaq

$101.77

0.05 (0.05%)

07:26
07/23/19
07/23
07:26
07/23/19
07:26
Hot Stocks
Nasdaq signs new agreement with Football Index »

Nasdaq announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

LII

Lennox

$264.15

-14.91 (-5.34%)

07:25
07/23/19
07/23
07:25
07/23/19
07:25
Recommendations
Lennox analyst commentary  »

Lennox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MRNS

Marinus Pharmaceuticals

$3.99

0.11 (2.84%)

07:25
07/23/19
07/23
07:25
07/23/19
07:25
Hot Stocks
Breaking Hot Stocks news story on Marinus Pharmaceuticals »

Marinus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$2.56

-0.04 (-1.54%)

07:23
07/23/19
07/23
07:23
07/23/19
07:23
Recommendations
Sorrento Therapeutics analyst commentary  »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSY

Hershey

$147.16

1.98 (1.36%)

07:23
07/23/19
07/23
07:23
07/23/19
07:23
Recommendations
Hershey analyst commentary  »

Hershey price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

INAP

Internap

$2.76

-0.23 (-7.69%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Hot Stocks
Internap launches Intelligent Monitoring managed cloud and monitoring service »

Internap Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLAB

Silicon Labs

$105.16

1.14 (1.10%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Initiation
Silicon Labs initiated  »

Silicon Labs initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 13

    Sep

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Downgrade
Viveve rating change  »

Mizuho double downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$54.64

-0.25 (-0.46%)

07:20
07/23/19
07/23
07:20
07/23/19
07:20
Recommendations
Mondelez analyst commentary  »

Mondelez price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

INTC

Intel

$51.36

1.1 (2.19%)

07:19
07/23/19
07/23
07:19
07/23/19
07:19
Initiation
Intel initiated  »

Intel initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 03

    Aug

TORC

ResTORbio

$11.18

1.15 (11.47%)

07:19
07/23/19
07/23
07:19
07/23/19
07:19
Hot Stocks
ResTORbio completes patient enrollment of Phase 3 PROTECTOR 1 trial »

resTORbio announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$264.15

-14.91 (-5.34%)

07:18
07/23/19
07/23
07:18
07/23/19
07:18
Recommendations
Lennox analyst commentary  »

Lennox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

AGTC

Applied Genetic

$3.89

0.02 (0.52%)

07:18
07/23/19
07/23
07:18
07/23/19
07:18
Hot Stocks
Applied Genetic completes enrollment of third group in Phase 1/2 clinical study »

Applied Genetic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

PEBO

Peoples Bancorp

$31.80

0.08 (0.25%)

07:18
07/23/19
07/23
07:18
07/23/19
07:18
Earnings
Peoples Bancorp reports Q2 EPS 46c with items, consensus 68c »

Reports Q2 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

07:16
07/23/19
07/23
07:16
07/23/19
07:16
Downgrade
Viveve rating change  »

Viveve downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCI

Rogers Communications

$53.30

0.005 (0.01%)

07:16
07/23/19
07/23
07:16
07/23/19
07:16
Earnings
Rogers Communications reports Q2 adjusted EPS C$1.16 vs. C$1.07 last year »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

JBT

John Bean Technologies

$121.10

-0.995 (-0.81%)

07:16
07/23/19
07/23
07:16
07/23/19
07:16
Recommendations
John Bean Technologies analyst commentary  »

John Bean Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 19

    Sep

IEX

IDEX Corp.

$164.74

0.31 (0.19%)

07:15
07/23/19
07/23
07:15
07/23/19
07:15
Recommendations
IDEX Corp. analyst commentary  »

IDEX Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

ROP

Roper Technologies

07:14
07/23/19
07/23
07:14
07/23/19
07:14
Recommendations
Roper Technologies analyst commentary  »

Roper Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

ACAD

Acadia

$25.97

0.28 (1.09%)

07:14
07/23/19
07/23
07:14
07/23/19
07:14
Recommendations
Acadia analyst commentary  »

Cantor sees failed trial,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 20

    Aug

PTI

Proteostasis

$0.89

-0.0209 (-2.31%)

, GLPG

Galapagos

$187.55

4.1 (2.23%)

07:14
07/23/19
07/23
07:14
07/23/19
07:14
Hot Stocks
Proteostasis appoints Geoffrey Gilmartin as Chief Medical Officer »

Proteostasis Therapeutics…

PTI

Proteostasis

$0.89

-0.0209 (-2.31%)

GLPG

Galapagos

$187.55

4.1 (2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 09

    Sep

RDHL

RedHill Biopharma

$8.35

0.24 (2.96%)

07:14
07/23/19
07/23
07:14
07/23/19
07:14
Earnings
RedHill Biopharma reports Q2 EPS (4c), consensus (35c) »

Reports Q2 revenue $1.6M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

XLNX

Xilinx

$124.24

1.52 (1.24%)

07:12
07/23/19
07/23
07:12
07/23/19
07:12
Initiation
Xilinx initiated  »

Xilinx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 08

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.